The Age of Blood Evaluation randomised controlled trial (ABLE): Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up
31 Oct 2017 in Health Technology Assessment, vol. 21
DOI: https://doi.org/10.3310/hta21620
Research output: Contribution to Journal › Article (Published)